Plasma antibody titres to heat shock proteins‐60, ‐65 and‐70: Their relationship to coronary risk factors in dyslipidaemic patients and healthy individuals

References

• Ross R. Mechanisms of disease. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115–26
   PubMed Web of Science ®Google Scholar
• Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C‐reactive protein, albumin, or leukocyte count with coronary heart disease: meta‐analyses of prospective studies. JAMA 1998; 279: 1477–82
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973–9
   PubMed Web of Science ®Google Scholar
• Rossi G. P., Cesari M., De Toni R., Zanchetta M., Maiolino G., Pedon L., et al. Antibodies to oxidized low‐density lipoproteins and angiographically assessed coronary artery disease in white patients. Circulation 2003; 108: 2467–72
   PubMed Web of Science ®Google Scholar
• Lamb D. J., El Sankary W., Ferns G. A. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 2003; 167: 177–85
   PubMed Web of Science ®Google Scholar
• Perschinka H., Mayr M., Millonig G., Mayerl C., van der Zee R., Morrison S. G., et al. Cross‐reactive B‐cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23: 1060–5
   PubMed Web of Science ®Google Scholar
• Mayr M., Metzler B., Kiechl S., Willeit J., Schett G., Xu Q. B., et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999; 99: 1560–6
   PubMed Web of Science ®Google Scholar
• Pockley A. G., Georgiades A., Thulin T., de Faire U., Frostegard J. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 2003; 42: 235–8
   PubMed Web of Science ®Google Scholar
• Veres A., Fust G., Smieja M., McQueen M., Horvath A., Yi Q. L., et al. Relationship of anti‐60 kDa heat shock protein and anti‐cholesterol antibodies to cardiovascular events. Circulation 2002; 106: 2775–80
   PubMed Web of Science ®Google Scholar
• Zhu J. H., Quyyumi A. A., Rott D., Csako G., Wu H. S., Halcox J., et al. Antibodies to human heat‐shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001; 103: 1071–5
   PubMed Web of Science ®Google Scholar
• Xu Q., Willeit J., Marosi M., Kleindienst R., Oberhollenzer F., Kiechl S., et al. Association of serum antibodies to heat‐shock protein 65 with carotid atherosclerosis. Lancet 1993; 341: 255–9
   PubMed Web of Science ®Google Scholar
• Kanwar R. K., Kanwar J. R., Wang D. M., Ormrod D. J., Krissansen G. W. Temporal expression of heat shock proteins 60 and 70 at lesion‐prone sites during atherogenesis in ApoE‐deficient mice. Arterioscl Thromb Vasc Biol 2001; 21: 1991–7
   PubMed Web of Science ®Google Scholar
• George J., Shoenfeld Y., Afek A., Gilburd B., Keren P., Shaish A., et al. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein‐65. Arterioscler Thromb Vasc Biol 1999; 19: 505–10
   PubMed Web of Science ®Google Scholar
• NCEP. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–97
   PubMed Web of Science ®Google Scholar
• Bjorntorp P. Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med 1992; 24: 15–8
   PubMed Web of Science ®Google Scholar
• Friedwald W. T., Levy R. J., Fredrickson D. S. Estimation of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifugation. Clin Chim Acta 1972; 18: 499–502
   Google Scholar
• Xu Q., Willeit J., Marosi M., Kleindienst R., Oberhollenzer F., Kiechl S., et al. Association of serum antibodies to heat‐shock protein 65 with carotid atherosclerosis. Lancet 1993; 341: 255–9
   PubMed Web of Science ®Google Scholar
• Scholin A., Siegbahn A., Lind L., Berne C., Sundkvist G., Bjork E., et al. CRP and IL‐6 concentrations are associated with poor glycemic control despite preserved beta‐cell function during the first year after diagnosis of type 1 diabetes. Diabetes Metab Res Rev 2004; 20: 205–10
   PubMed Web of Science ®Google Scholar
• Kocsis J., Veres A., Vatay A., Duba J., Karadi I., Fust G., et al. Antibodies against the human heat shock protein Hsp70 in patients with severe coronary artery disease. Immunol Invest 2002; 31: 219–31
   PubMed Web of Science ®Google Scholar
• Xu Q., Kiechl S., Mayr M., Metzler B., Egger G., Oberhollenzer F., et al. Association of serum antibodies to heat‐shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow‐up study. Circulation 1999; 100: 1169–74
   PubMed Web of Science ®Google Scholar
• Forouhi N. G., Sattar N., McKeigue P. M. Relation of C‐reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001; 25: 1327–31
   PubMed Web of Science ®Google Scholar
• Tamakoshi K., Yatsuya H., Kondo T., Hori Y., Ishikawa M., Zhang H., et al. The metabolic syndrome is associated with elevated circulating C‐reactive protein in a healthy reference range, a systemic low‐grade inflammatory state. Int J Obes 2003; 27: 443–9
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Buring J. E., Cook N. R., Rifai N. C‐reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 2003; 107: 391–7
   PubMed Web of Science ®Google Scholar
• Aronson D., Bartha P., Zinder O., Kerner A., Shitman E., Markiewicz W., et al. Association between fasting glucose and C‐reactive protein in middle‐aged subjects. Diab Med 2004; 21: 39–44
   PubMed Web of Science ®Google Scholar
• Pockley A. G., de Faire U., Kiessling R., Lemne C., Thulin T., Frostegard J. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens 2002; 20: 1815–20
   PubMed Web of Science ®Google Scholar
• Kervinen H., Huittinen T., Vaarala O., Leinonen M., Saikku P., Manninen V., et al. Antibodies to human heat shock protein 60, hypertension and dyslipidemia. A study of joint effects on coronary risk. Atherosclerosis 2003; 169: 339–44
   PubMed Web of Science ®Google Scholar
• Zhu J. H., Quyyumi A. A., Wu H. S., Csako G., Rott D., Zalles‐Ganley A., et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2003; 23: 1055–9
   PubMed Web of Science ®Google Scholar
• Kocsis J., Veres A., Vatay A., Duba J., Karadi I., Fust G., et al. Antibodies against the human heat shock protein Hsp70 in patients with severe coronary artery disease. Immunol Invest 2002; 31: 219–31
   PubMed Web of Science ®Google Scholar
• Mandal K., Jahangiri M., Xu Q. Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun Rev 2004; 3: 31–7
   PubMed Web of Science ®Google Scholar
• Ghayour‐Mobarhan M., New S. A., Lamb D., Livingstone C. L., Ferns G. A. A. Dietary antioxidants and fat are associated with plasma antibody titres to heat shock proteins‐60, ‐65 and ‐70 in subjects with dyslipidaemia. Am J Clin Nutr 2005; 81: 998–1004
   PubMed Web of Science ®Google Scholar